Amneal Pharmaceuticals, Inc.

Q4 2023 13F Holders

Symbol
AMRX
CUSIP
03168L105
Type
Equity
Class
COM STK CL A
Num filings
162
Total reported value, excl. options
$685 M
Manager Report Date Value ($000) Shares Option Type